首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experience.
【24h】

Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experience.

机译:等待列表中的急性肝衰竭紧急肝移植后的结果:单中心经验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Though emergency liver transplantation (ELT) is an established treatment for severe acute liver failure (ALF), outcomes are inferior to elective surgery. Despite prioritization, many patients deteriorate, becoming unsuitable for ELT. METHODS: We examined a single-centre experience of 310 adult patients with ALF registered for ELT over a 10-year period to determine factors associated with failure to transplant, and in those patients undergoing ELT, those associated with 90-day mortality. RESULTS: One hundred and thirty-two (43%) patients had ALF resulting from paracetamol and 178 (57%) from non-paracetamol causes. Seventy-four patients (24%) did not undergo surgery; 92% of these died. Failure to transplant was more likely in patients requiring vasopressors at listing (hazard ratio 1.9 (95% CI 1.1-3.6)) paracetamol aetiology (2.5 (1.4-4.6)) but less likely in blood group A (0.5 (0.3-0.9)). Post-ELT survival at 90-days and one-year increased from 66% and 63% in 1994-1999 to 81% and 79% in2000-2004 (p<0.01). Four variables were associated with post-ELT mortality; age >45 years (3 (1.7-5.3)), vasopressor requirement (2.2 (1.3-3.8), transplantation before 2000 (1.9 (1.1-3.3)) and use of high-risk grafts (2.3 (1.3-4.2). CONCLUSIONS: The data indicate improved outcomes in the later era, despite higher level patient dependency and greater use of high-risk grafts, through improved graft/recipient matching.
机译:背景/目的:尽管紧急肝移植(ELT)是严重急性肝衰竭(ALF)的既定治疗方法,但其结果不如择期手术。尽管优先考虑,但许多患者恶化,变得不适合ELT。方法:我们检查了10年期间登记的ELT的310名成年ALF患者的单中心经验,以确定与移植失败相关的因素,以及接受ELT的患者与90天死亡率相关的因素。结果:132例(43%)患者因对乙酰氨基酚而患有ALF,178例(57%)因非对乙酰氨基酚引起。七十四名患者(24%)没有接受手术;其中92%死亡。列表中需要升压药的患者移植失败的可能性更高(危险比1.9(95%CI 1.1-3.6))扑热息痛病因(2.5(1.4-4.6)),而A组血友病患者的失败率较低(0.5(0.3-0.9)) 。 ELT后90天和一年的生存率从1994-1999年的66%和63%增加到2000-2004年的81%和79%(p <0.01)。 ELT后死亡率与四个变量有关;年龄> 45岁(3(1.7-5.3)),需要升压药(2.2(1.3-3.8),2000年前的移植(1.9(1.1-3.3))和使用高风险的移植物(2.3(1.3-4.2))。 :尽管改善了患者/患者的依存度,并通过改进移植物/受体的匹配程度提高了对高风险移植物的使用率,但这些数据表明,晚期患者的预后有所改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号